TPP leak reveals harmful monopolies on medicines in Australia and globally

Public health expert Dr Deborah Gleeson says that many provisions  in the  TPP leaked text  will dramatically reduce access to affordable medicines, particularly in developing countries. While the Australian Government has said that the current law on 5-year data protection regime for costly biologics in Australia will not change, the text says that governments must deliver 'through other measures' an outcome comparable to eight years, meaning  an extra three years. . Read her full analysis here